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Abstract: 
Introduction: Various reports suggest linkage of protein expression to HPV status in cervical carcinomas. The aim of 
this study was to determine a possible association between HPV type, protein expression and DNA content in both 
preinvasive (CIN III) and invasive squamous cell carcinoma (SCC) of the cervix, as well as differences between the 
studied groups in these parameters.    
Materials and methods: Sections of formalin-fixed paraffin-embedded tumor tissue from 47 cases of CIN III and 60 
cases of invasive SCC of the cervix were subjected to HPV genotyping using LiPA (Line immuno-probe assay) and 
Flow cytometry for DNA content analysis. Also, immunohistochemical staining was performed. Obtained data were 
analyzed in SPSS using the Chi square test. 
Results: The major difference (p=0.007) between CIN III and invasive SCC of the cervix was found in DNA content - 
more aneuploid and tetraploid cases in invasive SCC of the cervix compared to CIN III. Although we observed a 
similar distribution of studied parameters in both groups, no statistically significant association was found between 
these parameters, except for p53 and pRb (p=0.018). 
Conclusion: The studied groups differ in DNA content. A significant association between analyzed parameters was 
observed in Invasive SCC of the cervix between p53 and pRb expression. 
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Pre-invasive, intraepithelial changes of the cervix are 
often asymptomatic. Cervical intraepithelial neoplasia 
(CIN) are diagnosed depending on the degree of 
epithelial thickness that is affected by intraepithelial 
changes and are described as defined: CIN I (lower 
grade lesion), CIN II (intermediate grade lesion) and 
CIN III (higher-grade lesion). CIN III is in fact cervical 
carcinoma in situ.  
Pre-invasive cervical lesions are not rare, but most of 
the lower graded dysplasia are reversible, although 
some may progress into higher-level dysplasia.  Only 
10-15% of CINII progress into carcinoma.1 Therefore, 
early intervention is very important.   
Cervical carcinoma in situ or CIN III is a malignant 
tumor, which can persist for years without becoming 
invasive. In about 30-50% of cases, CIN III progresses 
into invasive squamous cell carcinoma (SCC) of the 
cervix.2, 3 The event that makes the cancer invasive is 
the penetration of the basal membrane. 
Patients with invasive cervical SCC have the same 
epidemiologic characteristics as patients with CIN III, 
such as lower socio-economic status, early sexual 
activity, more partners, etc.  
It is well known that HPV infection is a key factor in 
the development of both in situ and invasive cancer.4 
However, years may pass before cervical carcinoma 
develops following HPV infection. Not every HPV 
infection will result in carcinoma development. 
Namely, in some cases it is possible for HPV to 
spontaneously disappear from the genital tract after 6-
12 months of persistention.5 
 
 Meljanac Salopek K 
Molecular and Experimental Biology in Medicine, 2019, 2(2): 16-20 
 
Transformation of the host cells, which leads to 
neoplasia, begins with the disruption of the circular 
viral genome - most commonly within the E2 gene, 
followed by viral genome integration into the host 
genome. Viral integration leads to loss of E2 function, 
which normally suppresses the transcription of known 
oncogenes, E6 and E7.6 
It is also known that p16 expression is associated with 
activity of the E6 protein in high risk HPV (hrHPV),6 
and that it interferes with the cyclin D/Rb signal 
pathway by binding to cyclin D.7  
The roles of proteins p53 and pRb in diseases related to 
HPV infections have also been previously described.8, 9  
Protein p53 is a tumor suppressor whose association 
with E6 in high risk HPVs leads to loss of p53 
activity.8 Therefore, it is expected that where hrHPV is 
found, there will be no p53 expression.  
Likewise, protein pRb, also a tumor suppressor, binds 
to another important oncoprotein - E7 in hrHPV. This 
E7-Rb binding plays an important role in the cell 
cycle.9 Therefore, no pRb expression is expected to be 
found in patients with hrHPV. 
Flow cytometry analysis of DNA content in neoplastic 
processes has both diagnostic and prognostic value. 
DNA content is actually the number of chromosomes 
in a cell. The flow cytometer detects changes in 
numbers of chromosomes, although it cannot detect 
smaller changes in chromosomes, like deletions or 
amplifications. The increase or decrease of one or more 
chromosomes is called aneuploidy, and the 
enlargement of the whole haploid set is called 
polyploidy.  DNA content in tumor cells often deviates 
from the normal diploid state. Also, association of 
aneuploidy with the progression of cervical cancer was 
found to be significant.10 
As most cervical lesions are related to HPV infection, 
the aim of this retrospective study was to determine 
potential differences in HPV status and HPV-related 
proteins, p16, pRb and p53, as well as DNA content 
between CIN III and invasive cervical carcinoma, 
which could lead to a better understanding of cell 
proliferation and development of cancer. 
Determining an association between p16, pRb and p53 
expression, HPV status and DNA content in each of the 
studied groups could help explain the significance of 
each parameter in cancer development. 
 
 
MATERIAL AND METHODS 
Case selection 
Paraffin embedded tumor tissue blocks were randomly 
selected from the archives of the Pathology 
Department, Clinical Hospital Center Zagreb and 
Zagreb University School of Medicine, from patients 
diagnosed with CIN III and invasive squamous cell 
carcinoma of the cervix, from 1978 to 2007. 
Tumor samples were histologically re-examined on 
tissue sections of formalin-fixed (10%) and paraffin-
embedded tissue stained with hematoxylin-eosin.  
There were 47 cases of CIN III in total, mean age 32.3 
years, and 60 cases of Invasive SCC of the cervix, 




DNA extraction from paraffin-embedded tissue 
sections (6x10 µm) was performed with commercially 
available QiAmp DNA Mini Kit (QIAGEN, Hilden, 
Germany), according to the manufacturer’s 
recommendations. The protocol started with 
deparaffinization and rehydration, followed by tissue 
lysis and centrifugation on filter columns. 
The detection of HPV DNA was performed using LiPA 
(Line immuno Probe Assay) by INNO-LiPA HPV 
genotyping v2 system (Innogenetics, Gent, Belgium), 
according to their protocol which is based on the 
amplification of the L1 region of HPV DNA. Results 




Immuno-enzymatic staining for detecting protein 
expression was performed on 4 μm thick paraffin 
sections immobilized on slides using the 
DakoCytomation Autostainer Instrument (Dako, 
Denmark) according to the protocol recommended by 
the manufacturer of each visualization kit: for p53 
EnVision kit (DAKO, Denmark), for pRB 
LSAB+System-HRP (Dako, Denmark) and for p16 
CINTec p16INK4A Histology Kit (Dako, Glostrup, 
Denmark). Counterstaining was performed with 
Hematoxylin (Dako). Nuclear and cytoplasmic staining 
of >30% of cells was considered positive. 
 
 
Flow cytometry for DNA analysis  
The samples (3x40µm tissue sections) were prepared 
using the method described by Hedley et al.11 Briefly, 
deparaffinization and rehydration of tissue sections 
preceded tissue lysis and filtration on nylon 
membranes, after which extracted nuclei were 
obtained. The nuclei were stained with propidium 
iodide. Cellular DNA content was analyzed the 
following day on the FACS Calibur Flow Cytometer 
(Becton Dickinson, San Jose, CA, SAD), at a 
wavelength of 488 nm and using red filter. The 
CellQuest program was used for the collection of 20 
000 nuclei per sample, and DNA histograms were 
analyzed in the ModFit LT V3.0 program (Verity 
Software House Inc., Topshame, ME and Becton 
Dickinson, SAD).    
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Samples with DNA index (DI) equals to one were 
considered diploid, those with 1<DI<2 were aneuploid, 




All statistical analyses were performed with the 
statistical package SPSS for Windows 9.0. The Chi 
square test was used to compare the studied groups. P 






From 47 cases with CIN III, only one (2.1%) was 
negative for HPV, and one (2.1%) was positive for low 
risk type of HPV, while the remaining 45 cases 
(85.7%) were high-risk types of HPV (Figure 1).   
From 60 cases of Invasive squamous cell carcinoma of 
the cervix, only three (5%) were negative for HPV, 
three (5%) were low-risk types of HPV, and 54 (90%) 
were high-risk types of HPV (Figure 1).   
With a statistical significance at p<0.05, we can 
conclude that there was no difference in HPV 




Four (8.5%) cases of CIN III could not be analyzed for 
p53 detection, while 29 from the remaining 43 cases 
(67.4%) were negative, and 14 of them (32.6%) were 
positive for p53 protein (Figure 1). 
 
Also, three (5%) cases of Invasive SCC of the cervix 
could not be analyzed for p53 detection, while 39 of 
the remaining 57 cases (68.4%) were p53-negative and 
18 of them (31.6%) were p53-positive (Figure 1). 
With a statistical significance at p<0.05, we can 
conclude that there was no difference in p53 detection 
expression between these two groups (p=0.917). 
From 47 cases of CIN III, four (8.5%) cases could not 
be analyzed for pRb detection, while from the 
remaining 43 cases, 30 (69.8%) were negative for pRb 
protein, and 13 (30.2%) were positive (Figure 1). 
There were three (5%) out of 60 cases with Invasive 
SCC of the cervix that could not be analyzed, while 
from the remaining 57 cases, 29 (50.9%) were negative 
for pRb protein and 28 (49.1%) were positive (Figure 
1). 
With a statistical significance at p<0.05, we can 
conclude that there was no difference in pRb detection 
expression between these two groups (p=0.057).  
There were 11 (23.4%) cases of CIN III that were 
negative for p16 protein, and 36 (76.6%) were positive 
(Figure 1). 
There was one (1.7%) case of Invasive SCC of the 
cervix that could not be analyzed for p16 detection, 
while from the remaining 59 cases, six were (10.2%) 
negative and 53 (89.8%) were positive for p16 protein 
(Figure 1). 
With a statistical significance at p<0.05 we can 
conclude that there was no difference in p16 expression 




From 47 CIN III cases there were 20 (42.5%) that 
could not be analyzed for DNA content, while all 27 
remaining cases were diploid (Figure 1). 
 
 
Figure 1. Association of analyzed parameters in study groups (Chi-square test, p<0.05) 
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Also, 17 (28.3%) cases of Invasive SCC of the cervix 
could not be analyzed, while from the remaining 43 
cases, nine (20.9%) were aneuploid, 30 (69.8%) diploid 
and four (9.3%) tetraploid (Figure 1). 
With a statistical significance at p<0.05 we can 
conclude that there were fewer aneuploidy and 
tetraploidy cases and more diploid cases in CIN III 
compared to Invasive SCC of the cervix (p=0.007).  
 
 
Association of HPV genotype, protein expression and 
DNA content 
No statistically significant association was found 
between the analyzed parameters in CIN III. In 
Invasive SCC of the cervix, a statistically significant 
association was only found between p53 expression 
and pRb expression (p=0.018) (Table 1).  
 
 
Table 1. Association of analyzed parameters in study groups 





Invasive SCC of the cervix 
(p value) 
HPV-p53 0.622 0.264 
HPV-pRb 0.74 0.307 
HPV-p16 0.755 0.582 
HPV-ploidy 0.804 0.507 
p53-pRb 0.182 0.018 
P53-p16 0.844 0.541 
p53-ploidy 0.387 0.707 
pRb-p16 0.599 0.058 
pRb-ploidy 0.555 0.193 
p16-ploidy 0.064 0.319 




The results for HPV prevalence in CIN III as well as in 
Invasive SCC of the cervix are as expected and as 
previously reported5, 12, 13 - they show a high incidence 
of hrHPV types. However, in our study there are more 
negative cases than in the previously reported studies 
mentioned earlier. 
It is possible that some negative cases are in fact false 
negative results because the DNA isolation was 
performed on paraffin-embedded tissue, which disrupts 
DNA, and therefore negatively affects HPV detection.5 
In addition, some parts of the viral genome may be lost 
during the integration process,6 for instance, the L1 
region. This can possibly lead to false negative results 
of HPV detection, because most commercially 
available detection methods are based on amplifying 
the above-mentioned region.  
Our results show that p53 expression has not been 
detected in most cases of CIN III and Invasive SCC of 
the cervix, which is contrary to some reported data,14,15 
but consistent with earlier findings reporting that p53 
expression is in negative correlation with HPV 
infection.15 However, this could not be confirmed in 
our study. 
In most of CIN III cases, pRb expression was not 
detected, while in cases of Invasive SCC of the cervix, 
pRb expression was detected in less than 50% of the 
cases. Our results are not consistent with some 
previous reports14 where pRb was detected in nearly all 
cases in both studied groups. We expected to find little 
or no pRb expression as was previously reported in 
another study.16 However, our results also showed an 
increase of pRb expression as the disease progresses, 
which is contrary to our expectations and previously 
reported results where the expression of pRb in cases 
with CIN III was higher compared to cases with 
Invasive SCC of the cervix.16 
In concordance with previously reported data, p16 
expression was detected in CIN III and in Invasive 
SCC of the cervix. Higher levels of p16 are expected to 
be found in higher levels of HPV-related 
malignancies17, 18 Only one study has shown that no 
significant correlation between p16 expression and 
HPV types was found in cervical neoplasia.15 Our 
study also showed no statistically significant 
association between p16 expression and hrHPV 
detection, although we observed that hrHPV, as well as 
p16 expression, was detected in both study groups. 
Although previously reported data show a high 
percentage (>80%) of aneuploidy in CIN III, our cases 
are all diploid. It was also reported that aneuploidy is 
positively correlated with hrHPV,19, 20 which could not 
be confirmed in our study. 
A high percentage of aneuploidy was also reported in 
Invasive SCC of the cervix. Though our results show a 
high incidence of diploid cases, our results also show 
aneuploidy in some cases. Interestingly, we found 
tetraploidy (9%) in Invasive SCC of the cervix, which 
was not previously reported.9, 21  
Also, as previously reported9 we confirmed with 
statistical significance (p=0.007) that DNA content 
changes with progression of cervical cancer. 
A possible explanation for all these differences is the 
uneven distribution of successfully analyzed cases in 
studied groups. Unfortunately, not all cases could be 
analyzed due to low material quality, which is common 
in older paraffin-embedded samples. 
Although we expected to find p16 expression and no 
p53 and pRb expression in cases with hrHPV, as well 
as changes in DNA content, we could not find any 
statistically significant association between studied 
parameters, except between p53 and pRb expression. 
In conclusion, we found no statistically significant 
differences in HPV prevalence and protein expression 
between CIN III and Invasive SCC of the cervix. The 
only statistically significant difference between studied 
groups was in DNA content. 
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Also, the only statistically significant association of 
studied parameters was found in Invasive SCC of the 
cervix between p53 expression and pRb expression 
(p=0.018). 
Although we found some differences between the 
studied groups, further investigation is needed for a 
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